Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Clinical trial NCT03141034 · COMPLETED
Trial details
- NCT number
- NCT03141034
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2023-04-14
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.